Trent Northcutt has been named vice president of sales for Alphatec Spine (Carlsbad, California). Northcutt was hired in 2004 as director of business development for Alphatec Manufacturing and was then promoted to director of national sales. In 2005, he was named regional sales vice president for the West. Alphatec manufactures products for the surgical treatment of spine disorders, primarily spine fusion.

James Pusey, MD, has resigned as president and CEO of OrthoLogic (Tempe, Arizona) to pursue other opportunities. John Holliman III, a director of OrthoLogic since September 1987 and chairman of the board since August 1997, will assume the title of executive chairman and will lead the company's business and corporate strategic activities. Randolph Steer, MD, PhD, has been named president of OrthoLogic, directing the company's strategy and operations in all clinical development and regulatory areas. Steer has been an independent pharmaceutical, biotechnology and medical devices consultant since 1989, and has provided consulting services to OrthoLogic since 2002. OrthoLogic is focused on the development of two product platforms: Chrysalin (TP508), a synthetic peptide; and AZX100, a preclinical 24-amino acid peptide.